Trade TRAW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Traws Pharma, Inc. (TRAW) is trading at US$0.50, up 0.24% today as of Sep 22, 15:44 EDT. The company has a market capitalisation of US$8.15M. Over the past 52 weeks, TRAW has traded between US$0.43 and US$3.27. On Syfe you can trade TRAW with $0 commission and add it to your watchlist.
| Previous close | US$0.50 |
|---|---|
| Market cap | US$8.15M |
| 52-week range | US$0.43 – US$3.27 |
| Volume | 121.91K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Traws Pharma, Inc.
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Year: 2013
Traws Pharma Says Updated Toxicology Data Being Developed on Influenza Prophylaxis Program
Jun 22, 12:23 PM · MT Newswires
Top Premarket Decliners
Jun 15, 11:41 AM · MT Newswires
--Ladenburg Thalmann Downgrades Traws Pharma to Neutral From Buy, Price Target is $3
Jun 15, 10:59 AM · MT Newswires
Traws Pharma Delays Phase 2 Influenza Study After UK Regulatory Review; Shares Down Pre-Bell
Jun 15, 10:42 AM · MT Newswires
Sector Update: Healthcare Stocks Lower Late Afternoon
May 8, 7:58 PM · MT Newswires
Traws Pharma, Inc. (TRAW) stock is trading at US$0.50, +0.24% from the previous close of US$0.50.
The market cap for Traws Pharma, Inc. (TRAW) stock is approximately US$8.15M.
The 52-week high for Traws Pharma, Inc. (TRAW) stock is US$3.27.
The 52-week low for Traws Pharma, Inc. (TRAW) stock is US$0.43.
Traws Pharma, Inc. (TRAW) does not currently pay a dividend.
Stay on top of TRAW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
